Rob Schinagl

Rob Schinagl is a seasoned professional in project management and leadership within the pharmaceutical industry, currently serving as Senior Director of Global Project Management and Leadership at Daiichi Sankyo, Inc. since March 2023. Previously, Rob held the position of Vice President of Program and Alliance Management at OncoSec from May 2021 to March 2023, and Chief Operating Officer at Prothex Pharma from August 2018 to May 2021. Additional roles include Vice President of Project Management at Drais Pharmaceuticals and Associate Vice President of Project, Portfolio and Alliance Management at ImClone Systems. Rob's career began with positions such as Project Manager at Quintiles and Assistant Director of Preclinical Research at Osiris Therapeutics, building a strong foundation with a Ph.D. in Bioengineering, an MSE in Bioengineering, and a BSE in Bioengineering and Mechanical Engineering from UC San Diego and the University of Pennsylvania.